Background-Preoperative factors associated with increased mortality and worse outcome after tricuspid valve replacement in patients with severe tricuspid regurgitation are poorly understood. Methods and Results-We retrospectively analyzed 189 patients (37% men; age, 67.5Ϯ11.3 years) who underwent tricuspid valve replacement for severe tricuspid regurgitation. Operative mortality rate was 10%, and was associated with intra-aortic balloon pump (odds ratio, 3.2; 95% confidence interval, 1.9 to 5.6; PϽ0.0001) or the presence of severe symptoms (New York Heart Association class IV relative to classes II and/or III) at the time of surgery (1.7; 95% confidence interval, 1.05 to 2.8; Pϭ0.02). At the end of follow-up (29.3Ϯ27.1 months), 70 patients (37%) died, 6 (3%) needed tricuspid reoperation, and 41 (21.7%) were readmitted for heart failure. Seventy-eight patients (41.3%) were free from cardiovascular events (death, tricuspid reoperation, or heart failure admissions). The only echocardiographic parameter independently associated with adverse outcomes was a decrease in the right index of myocardial performance ratio. All-cause mortality was independently associated with a higher Charlson index (hazard ratio, 1.18; 95% confidence interval, 1.01 to 1.36; Pϭ0.03), shorter right index of myocardial performance ratio (0.91; 95% confidence interval, 0.87 to 0.96; Pϭ0.005), and preoperative New York Heart Association IV class (1.71; 95% confidence interval, 1.3 to 2.2; PϽ0.0001). In 68 patients with isolated tricuspid valve replacement, the associations between short right index of myocardial performance ratio, high Charlson index, New York Heart Association class IV, and increased mortality remained significant. Conclusions-Tricuspid valve replacement for severe tricuspid regurgitation can be performed with an acceptable operative mortality if patients undergo surgery before the onset of advanced heart failure symptoms. Late mortality is associated with a high preoperative Charlson index, short right index of myocardial performance ratio, and advanced
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Appropriate patient selection and optimal timing for TVR are crucially important in yielding a good clinical outcome, but there is a lack of objective criteria to guide clinicians. Severe TR may be present without the classic clinical features. 2 Subjective symptoms are often nonspecific, and may become evident only after irreversible end-organ damage occurs. 3 Echocardiography is invaluable in assessing TV structure and identifying other cardiac abnormalities that might influence TV function, but the complex geometry of the right ventricle (RV) makes it difficult to attain accurate and reproducible measurements of RV size or function. 2 Doppler echocardiography is complementary and permits estimation of the severity of TR 4 -9 and RV systolic pressure, but accurate estimation of right atrial (RA) pressure (RAP) using the inferior vena cava is difficult in the presence of severe TR. A few studies have dealt with this important issue, but they have been limited by small study populations with various causes for TR and a lack of comprehensive echocardiographic evaluation. 10, 11 In the present study, we retrospectively analyzed patients with severe TR to identify preoper-ative clinical and echocardiographic parameters associated with operative and long-term mortalities after TVR surgery.
Methods

Study Subjects
The study was a retrospective review of our experience with TVR for severe TV regurgitation. From January 1997 through December 2007, 2031 patients underwent TV repair or TVR at our clinic. We excluded patients with previous tricuspid surgery (nϭ183), congenital TV disease (nϭ608), carcinoid heart disease (nϭ103), and TV stenosis (nϭ19) and patients who had repair (nϭ870), leaving 248 patients. Additionally, the study includes only patients having TVR who had complete echocardiographic assessment at the Mayo Clinic; the total number of subjects in the investigation is 189. Severe TR was defined by a TR jet area Ͼ30% of the RA area, inadequate cusp coaptation, and systolic flow reversal in the hepatic veins. The study was approved by our institutional review board.
Baseline Clinical Assessment and Management
Each patient's history was recorded at baseline by a staff cardiologist. Coexisting conditions were evaluated by means of the Charlson index. 12 The Charlson comorbidity index predicts the 1-year mortality for a patient who may have a wide range of conditions, including heart disease from different origins. It contains different categories of comorbidities (myocardial infarction, congestive heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic pulmonary disease, rheumatic disease, peptic ulcer disease, liver disease, diabetes mellitus, hemiplegia or paraplegia, renal disease, any malignancy including lymphoma and leukemia [except malignant neoplasm of skin], and AIDS/HIV). Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with this condition. Then the scores are summed to give a total score that predicts mortality. We have also calculated the published Ambler score. 13 Operative mortality was defined as death within 30 days of TVR or during the same index hospitalization. Congestive heart failure was diagnosed on the basis of criteria from the Framingham Heart Study. 14 Isolated TV surgery was defined as TVR with no concomitant or previous left-sided valvular surgery and no concomitant bypass surgery. Clinical management was determined independently by the patient's physician using all information available.
Follow-Up and Outcomes
Clinical follow-up was obtained by review of medical records, surveys, and telephone interviews. The cause of death was determined by review of medical records and death certificates. Cardiovascular events included readmission for heart failure or sudden death. Sudden death was defined according to the criteria of Hinkle and Thaler 15 ; sudden cardiac death was abrupt death occurring in the setting of progressive congestive heart failure or an episode of congestive heart failure in the preceding 12 months. We defined dominant right failure on the basis of on the presence of weakness, bloating, lack of appetite, neck vein distension, ascites, positive hepatojugular reflux, and severe edema. We defined dominant left heart failure on the basis of the presence of paroxysmal nocturnal dyspnea, orthopnea, acute pulmonary edema, cardiogenic shock, and/or rales. End points were all-cause mortality and cardiovascular mortality (defined as mortality related to intractable right heart failure or arrhythmic death).
Echocardiographic Measurements
Two-dimensional transthoracic echocardiography was performed in a standard manner. All images and measurements from the echocardiograms were reviewed offline for this study. Left ventricular diameters, ejection fraction, and mass were measured as recommended by current guidelines. 16 The RA size and RV size and function were graded visually and qualitatively on a scale of 1 to 4 scale (normalϭ1, mildϭ2, moderateϭ3, severeϭ4) using the apical 4-chamber, RV inflow, parasternal long-axis, parasternal short-axis, and subcostal views. 16 For each finding (RA enlargement, RV enlargement, and RV dysfunction), we divided the cohort into 2 groups: normal/mild and moderate/severe abnormalities. Care was taken to evaluate a true nonforeshortened apical 4-chamber view, oriented to obtain the maximum RV dimension, before making these estimations.
Doppler Echocardiography
All patients had a complete Doppler echocardiographic study using multiple windows during the same examination. Patients were instructed to breathe normally. All measurements of TR, including peak velocity, were determined in midsystole during end expiration. We estimated RAP by the inferior vena cava diameter and its response to inspiration, as previously described. 17 We used the modified Bernoulli formula (4ϫpeak TR velocity 2 ϩRAP) to estimate peak pulmonary arterial pressure. Right ventricular function was assessed by the right index of myocardial performance (RIMP). 18, 19 The RIMP is a global estimate of both systolic and diastolic function of the RV. It is based on the relationship between ejection and nonejection work of the heart. It is defined as the ratio of the sum of isovolumic relaxation time (IVRT) and isovolumic contraction time (IVCT) divided by ejection time (ET): (IVRTϩIVCT)/ET. The upper reference limit of RIMP is 0.40 on the basis of recent guidelines. 20 The tricuspid closure-opening time (TCO) was measured with continuous Doppler of the TR jet (time from the onset to the cessation of the jet) and encompasses IVCT, ET, and IVRT. The ET was measured with pulsed Doppler of the RV outflow (time from the onset to the cessation of flow). The RIMP ratio was calculated as follows: (TCOϪET)/ET ( Figure 1A) .
The duration of the signals was determined from 3 consecutive beats in patients in sinus rhythm and in at least 7 consecutive beats in patients in atrial fibrillation to minimize measurement variability.
Statistical Analysis
Continuous normally distributed parameters are presented as meanϮSD and compared by use of the Student t test. Ordinal and/or nonnormally distributed variables (Charlson index, Ambler score, cardiopulmonary bypass time, cross-clamp time, postoperative red blood cell transfusion, mechanical ventilation time, duration of intensive care unit stay) were presented by median and first and third quartiles and compared by use of the nonparametric Wilcoxon rank-sum test. Categorical data were compared between groups by use of 2 tests or the Fisher exact test when the expected value in one of the cells was Ͻ5. Logistic regression models were used to analyze independent associations with operative mortality (operative mortality as a dependent variable and baseline clinical and echocardiographic parameters as independent variables). Survival distributions were calculated according to the Kaplan-Meier method and compared by means of the log-rank test. Patients were censored at the time of last follow-up or at the time of a second cardiac surgery for the TV if performed. For each patient in the high RIMP (Ͼ0.48) or mild symptomatic status (New York Heart Association [NYHA] II) subgroups, the corresponding average age-and gender-specific annual mortality was obtained from US Census Bureau national life tables. On the basis of these mortality data, the probability of cumulative expected survival was determined, and an expected survival curve was constructed. The observed total mortality survival distribution of the RIMP ratio Ͼ0.48 or NYHA II groups was then compared with the expected mortality survival distributions with a 1-sample log-rank test. [21] [22] [23] [24] Unadjusted and adjusted Cox proportional hazards analyzed the association of the clinical and echocardiographic parameters with mortality and cardiac events with calculation of hazard ratios (HRs). The adjusted model considered unadjusted significant variables (PϽ0.05) with model selection using the stepwise method (backward and forward methods resulting in the same model). To correct for possible overfitting of the model, we restricted the independent variables to the following: age, NYHA functional class, Charlson comorbidity index, creatinine, and the RIMP ratio. Variables assessing baseline clinical characteristics were entered first, and the RIMP ratio was added consecutively to the models. To exclude possible multicollinearity, we used multicollinearity diagnostic statistics and examined the variance inflation factor. All P values were 2 sided, and values of Ͻ0.05 were considered to indicate statistical significance. All data were analyzed with the JMP System software version 8.0 or SAS (for the 1-sample log-rank test; SAS Institute, Inc., Cary, NC). All authors participated in designing the study, collecting and analyzing data, and drafting and revising the manuscript. Table 1 shows the baseline characteristics of the patients enrolled (nϭ189) overall according to operative mortality and according to whether they had isolated TVR. The mean age was 67.5Ϯ11.3 years, and 37% were men. A total of 129 patients (68.2%) were in atrial fibrillation at baseline; 16 of them (12.4%) had a Maze procedure performed at the time of TVR. The cause of TR was functional in 71% of patients. The causes of TR in the 29% patients with nonfunctional disease were rheumatic disease (nϭ25), pacemaker lead impinging on the leaflets (nϭ11), myxomatous disease (nϭ7), endocarditis (nϭ4), idiopathic annular dilatation (nϭ3), radiation-induced injury (nϭ2), and ergot-induced valvulopathy (nϭ1).
Results
Baseline Characteristics
All patients were symptomatic. They were classified as NYHA functional class II (16%), III (54%), or IV (30%). Concomitant procedures were performed in 64.5% of patients; 26.5% required coronary artery bypass surgery, and 46.5% had repair or replacement of other valves (17% aortic, 34.4% mitral, 5% both aortic and mitral). Many patients (46%) had previous left-sided valve surgery (14% aortic, 32% mitral). The remaining 68 (40%) had isolated TV surgery. The mean interval between the operations was 9.4Ϯ7.4 years. Baseline echocardiographic examination showed the following mean values: left ventricular end-diastolic diameter of 47.1Ϯ7.9 mm, left ventricular ejection fraction of 56.2Ϯ12.2%, and TR peak velocity of 2.7Ϯ0.7 m/s. Estimated RAP by the inferior vena cava method was elevated in all patients, with a mean of 16.7Ϯ4.3 mm Hg. The RV dimensions were estimated as normal in 66 (35%), mildly dilated in 13 (7%), moderately dilated in 49 (26%), and severely dilated in 61 (32%). Right ventricular function was estimated as normal in 107 (57%), mildly impaired in 25 (13%), moderately impaired in 45 (24%) and severely impaired in 11 (6%). Table 2 shows the postoperative outcomes in all patients and divided into patients with and without postoperative mortal- The RIMP ratio is calculated as follows: (TCOϪET)/ET. Note that the TR signal is dense, consistent with severe TR, but has a symmetrical contour and high peak velocity, ending considerably after the end of the QT interval. An increase in systolic PAP results in an equal rise in RV pressure (RVP), and once the pulmonary valve is closed (pink 2), the pressure in the RV must fall from a higher point to reach the pressure of the RA (green 2). Furthermore, an increase in end-diastolic RVP (pink 3) to end-diastolic PAP (green 3) may also increase the IVCT, resulting in an increased RIMP ratio. B, A patient with a pseudonormalized RIMP ratio. The increased RAP causes the tricuspid valve to open earlier (green 2) on the steeper curve of ventricular relaxation curve, thereby shortening the isovolumic relaxation interval and the time between the cessation and beginning of tricuspid inflow. Furthermore, a decrease in end-diastolic RVP (pink 3) to end-diastolic PAP (green 3) gradient may also decrease the IVCT. These result in a smaller PAP to RAP difference (blue area), shorter TCO, and decreased or pseudonormalization of the RIMP ratio. Note that the TR signal is dense and dagger shaped, consistent with rapid equalization of RV to RAP gradient during systole. RVOT indicates RV outflow tract. 15) . When looking at the isolated TVR group, we found that the only significant association with early mortality was the presence of NYHA class IV (odds ratio 3.0; 95% CI, 1.02 
Operative Outcomes and Operative Mortality
Postoperative Outcomes and Clinical Parameters Associated With Long-Term Mortality
The mean follow-up duration after surgery was 29.3Ϯ27.1 months. Fifty-one of the 170 patients (30%) who survived surgery died during follow-up; 41 patients required readmission because of cardiovascular problems; and 6 underwent a second cardiac surgery for the TV. The cause of mortality in patients who survived the index surgery was progressive right heart failure in 18 patients, left heart failure in 7 patients, sudden arrhythmic cardiac death in 4 patients, endocarditis in 1 patient, other types of infection in 8 patients, stroke in 1 patient, and metastatic cancer in 1 patient. The cause of death was undetermined in 11 patients. Among the patients who needed a second TV surgery, 2 patients had bioprosthesis structural deterioration, 1 bioprosthesis had a periprosthetic leak, 1 bioprosthesis had acquired an injury to the leaflet from a pacemaker wire, and 2 mechanical prostheses had valve thrombosis when the international normalized ratio was subtherapeutic. Seventy-eight patients (41.3%) remained event free at the end of follow-up. The overall survival rates were 75.6Ϯ3.2% and 55.9Ϯ4.9% at 1 and 5 years, respectively. Table 3 shows the results of unadjusted Cox proportional hazard analysis for all-cause mortality in all patients and patients who had isolated TVR. The clinical parameters associated with increased mortality were older age (HR, 1.02; 95% CI, 1.0 to 1.04 for each year; Pϭ0.04), Charlson comorbidity index (HR, 1.27; 95% CI, 1.13 to 1.42 for 1 grade; PϽ0.0001), NYHA functional class grade (HR, 2.0; 95% CI, 1.4 to 2.9 for 1 grade; Pϭ0.0002), Ambler score (HR, 1.06; 95% CI, 1.03 to 1.09 for 1 grade; PϽ0.0001), tissue valve prosthesis (HR, 1.5; 95% CI, 1.09 to 2.3; Pϭ0.01), and creatinine level (HR, 1.85; 95% CI, 1.33 to 2.4 for an increase of 1 mg/dL; Pϭ0.0007). Year of operation, presence of liver or pulmonary disease, need for operation on other valves, hemoglobin, platelets, or hepatic enzyme levels did not affect mortality rates. Importantly, the associations between increased creatinine, higher Charlson index, higher Ambler score, higher NYHA class, and increased mortality remained significant in the isolated TVR group.
Echocardiographic Parameters Associated With Long-Term Mortality
The only echocardiographic parameters associated with longterm total mortality and cardiac compound outcome (cardiac death or congestive heart failure readmission) in Cox proportional hazard unadjusted analysis were related to timing of right-sided flows ( Table 3 and Figure 1 ). Decreased duration of TR flow was the strongest association with all adverse outcomes (HR, 0.93; 95% CI, 0.88 to 0.97; Pϭ0.005; and HR, 0.93; 95% CI, 0.88 to 0.98; Pϭ0.01 for all-cause mortality and cardiac compound outcome, respectively). An increase in RIMP ratio coincided with a decreased risk for death resulting from any cause (HR, 0.85; 95% CI, 0.72 to 0.99 for each increase by 1 in the ratio; Pϭ0.04) and the sum of isovolumic contraction and IVRT (TV closure to TV opening time-RV ejection time; HR, 0.92; 95% CI, 0.86 to 0.98; and HR, 0.93; 95% CI, 0.87 to 0.99; Pϭ0.03 for all-cause mortality and cardiac compound outcome, respectively; Figure 2 ). Neither qualitatively estimated RV function or size nor TR peak velocity (Pϭ0.4) was associated with long-term mortality. Of note, the associations between lower RIMP, short TCO time, TCO-RV ET, and increased mortality remained significant in the isolated TVR group as well.
In adjusted Cox hazard analysis including RIMP ratio, age, NYHA class, Charlson index, and creatinine, survival was independently associated with low Charlson index (Pϭ0.04), preoperative NYHA class ϽIV (PϽ0.0001), and an increased RIMP ratio (Pϭ0.005; Table 4 ). Cox proportional hazards model adjusted for patient characteristics with mortality in the isolated TVR group is presented in Table 5 . Because of sample size, we restricted explanatory variables to the following: NYHA class, Charlson comorbidity index, and creatinine with and without the RIMP ratio. The results of the adjusted model show that the RIMP ratio continues to be independently associated with mortality after adjustment for clinical characteristics in the isolated TR group and in the entire cohort.
New York Heart Association Functional Class and Mortality After Tricuspid Valve Replacement
Operative mortality was significantly related to NYHA class before surgery, with no mortality in patients with NYHA class II (0 of 30), 8.9% mortality with NYHA class III, and 17.9% mortality with NYHA IV (Pϭ0.02). NYHA functional class was also found to be strongly linked to long-term mortality in unadjusted and adjusted analyses. A clear difference was noted between patients with NYHA IV and others (Figure 3) . The hazard ratio for all-cause mortality was 2.0 (95% CI, 3 to 2.1; PϽ0.0001) in patients with NYHA IV, regardless of the need for concurrent surgical procedure (HR, 2.1; 95% CI, 1.3 to 3.2; Pϭ0.003) or performance of isolated tricuspid surgery (HR, 2.1; 95% CI, 1.4 to 3.2; Pϭ0.001). The 5-year survival rates were 69.3Ϯ12.7%, 63.5Ϯ6.5%, and 36.3Ϯ7.9% in patients with NYHA functional class II, III, and IV, respectively (Figure 3 ). Of note, even in patients with mild symptoms (NYHA class II), 5-year survival was lower than expected for age and gender (Pϭ0.02).
Discussion
Information on the outcome of TV surgery is scarce, with reported hospital mortality ranging from 8.8% to 25% and 5-year actuarial survival rates of 41% to 44%. 11, 25 These early reports identified age and the number of prior valve surgeries as independent predictors of poor clinical outcome, but they were limited by their small population and lack of echocardiographic measures. 11 Our main finding is that good outcomes for TVR are achievable in properly selected patients. The operative mortality is reduced to Ϸ6% when patients are operated on in an earlier symptomatic state (NYHA ϽIV) or when hemodynamically stable (no need for IABP). Furthermore, if the patient is operated on before echocardiographic evidence of increased RV filling pressure, survival may be improved even further. We believe that the prior poor outcomes of TR surgery are related to the difficulty in interpreting symptoms as caused by TR and in making a clinical diagnosis, which leads to delaying surgery until a very advanced stage. A third of our patients had preoperative NYHA functional class IV, which suggests that surgical timing was late in many patients. We believe that the surgical delay was due partly to the absence of guidelines for surgical timing. Therefore, the establishment of guidelines with widely used clinical and echocardiographic parameters is critically important. On the basis of our observations, we propose that surgical correction of severe TR should be considered before the development of advanced heart failure (NYHA IV) or evidence of increased RV filling pressure, as shown by pseudonormalization of the RIMP ratio. Given a higher TR recurrence rate after TR repair, we wanted to study a homogeneous patient population that underwent TVR and excluded the patients with TV repair from our analysis. Although the study included only patients who had TVR, the findings may apply to patients undergoing TV repair.
Surgical Mortality
The operative mortality in our series was 10.0%, comparable to published reports. 3 Our main finding was that the operative mortality in patients with milder symptoms (NYHA II/III) or no hemodynamic deterioration (no need for IABP) was Ϸ6%, stressing the fact that good outcomes of TV surgery are achievable if patients are referred early before the occurrence of severe symptoms. Surprisingly, the only parameters associated with increased operative mortality were typical parameters indicating left heart failure (need for IABP, NYHA functional class, and creatinine), not right heart failure. On the other hand, increased age was not associated with increased early mortality and should not affect the decision of whether to perform surgery in symptomatic patients with severe TR. The same parameters held true when only the patients with isolated TVR were analyzed. The cause of immediate postoperative mortality was rarely right heart failure. We speculate that, although right heart failure at baseline is associated with adverse long-term outcomes (mortality and heart failure), it is usually manageable by diuretics and inotropes in intensive care units immediately after surgery and rarely results in early mortality. Left heart failure, on the other hand, may result in acute respiratory and hemodynamic deterioration, causing death. The TR peak velocity was not associated with increased risk of early postoperative or long-term mortality. We believe that the pulmonary pressure may reflect the opposing effects on outcome of increased left-sided filling pressures (increased pulmonary pressure) and decreased stroke volume and advanced RV failure (decreased pulmonary pressure).
Long-Term Mortality and Outcome
The majority of patients with functional TR undergo TV repair. However, those with very severe to torrential TR combined with severe RV enlargement and apical tethering of the TV were thought to have a low likelihood of durable repair, and underwent TVR. The results confirm that the risk of TVR remains significant in nonselected patients, and that the clinical decision-making process should remain individualized on the basis of preoperative predictors of outcome. Present guidelines advocate TVR only for severe symptomatic TR. 2 The significant decline in late survival in patients with NYHA class IV suggests that we should intervene in an earlier stage when patients are only mildly symptomatic. Furthermore, the failure to achieve normal life expectancy even in patients with very mild symptoms stresses the need for more sensitive predictors of outcome. Importantly, neither qualitatively estimated RV enlargement nor dysfunction, even when severe, was associated with worse outcome. We believe that the lack of predictive value for the qualitative right-sided parameters merely reflects the fact that the complex structure of RV is incompletely visualized in any echocardiographic view and that ejection-phase indexes overestimate ventricular contractility because of favorable afterload conditions in the presence of severe regurgitation. The choice to proceed to TVR instead of TV repair in patients with functional TR was individualized and based on cardiologist and surgeon preference. The main factors guiding the decision to proceed with TVR are the presence of marked apical displacement of the valve (tethering), torrential TR deemed unrepairable, and severe RV dysfunction and dilatation. Although the study included only patients who had TVR, the results may apply to patients undergoing TV repair because cardiologists frequently will not make the determination about whether a patient with advanced tricuspid disease will be repaired or replaced preoperatively.
Echocardiographic Parameters Associated With Long-Term Mortality
Doppler-derived indexes, combining systolic and diastolic intervals of the right heart cardiac cycle, are used in assessing global RV function and predicting outcome in patients with primary pulmonary hypertension and dilated cardiomyopathy. 18 During RV contraction, 2 flow signals are in play: the regurgitant flow through the TV (TCO) and the forward flow through the pulmonic valve (ET). The difference in time between these 2 flow durations is the period during which RV systole yields no forward flow (TCOϪET), ie, the sum of isovolumic contraction and relaxation. The RIMP is the ratio of RV systolic time spent on no forward flow (TCOϪET) over the time of forward flow (ET), and it is a wellrecognized echocardiographic parameter assessing RV function 18, 19, 26 (Figure 1A) . Working through the mathematical relationships gives RIMPϭ(TCOϪET)/ET, which can be rearranged to RIMPϭTCO/ETϪ1. Hence, RIMP is proportional to TCO/ET. ET was not associated with adverse outcome; however, a short TCO (resulting in a short RIMP) was found to be significantly associated with adverse outcome (Table 3) . Tricuspid regurgitant flow (TCO) continues as long as the systolic pressure in the RV is higher than the pressure in the RA. Therefore, an increase in the pressure in the RA and/or a decrease in systolic pressure in the RV will result in a decrease in the RIMP ratio. Because systolic pulmonary artery pressure is linearly correlated to systolic pressure in the RV in the absence of pulmonic stenosis, a decrease in systolic pulmonary artery pressure will result in a lower RIMP ratio. To validate the relationship between the RIMP ratio and the pressure difference between the pulmonary artery to right atrium, we have analyzed for 26 patients who had a right heart catheterization on the day of their echocardiographic evaluation and found it to be significant (ϭ0.48; Pϭ0.02). The Spearman association between TCO and mean Pa to mean RA pressure difference in the same 26 patients was highly significant (ϭ0.87; Pϭ0.001).
In summary, patients with severe TR and a low RIMP (or short TCO) have high pressure in the RA and/or low systolic pulmonary artery pressure (reflecting a failing RV unable to generate high pressures) and are at increased risk of morbidity and mortality after TV surgery.
Study Limitations
We did not have a control group, and cannot conclude that surgery is better than medical therapy. The observational retrospective nature of the data does not allow demonstration
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of causation between the dependent variables and the outcome of TVR, stressing the need for prospective validation of our findings. We analyzed only patients in need of valve replacement. Most of these patients have torrential TR caused by inadequate coaptation and severe leaflet tethering. Thus, our results may not be applicable to the more common patients with less severe TR still amenable to repair. The RV is a complex structure and is incompletely visualized in any single 2-dimensional echocardiographic view. For the assessment of the RV, the measures were obtained from appropriately oriented 2-dimensional views with the use of welldefined accepted landmarks and in agreement with the current guidelines published by the American Society of Echocardiography. 16 Three-dimensional echocardiography or magnetic resonance imaging with quantitative measurement might be useful to further evaluate a link between function and outcome in future studies. Analysis of relations between echocardiographic Doppler variables, and hemodynamic measurements was not performed, and validation of our assumptions on the hemodynamic significance of those variables in the context of severe TR requires further studies.
Conclusions
Outcomes after TVR are heterogeneous. Patients with advanced heart failure status incur high operative mortality and poor long-term survival, but those operated on at a less advanced stage enjoy acceptable operative mortality and good long-term survival. Restoration of normal life expectancy was not achieved even in patients with mild symptoms, stressing the need to assess for more sensitive markers of outcome (ie, cardiopulmonary exercise test or hemodynamic or other echocardiographic variables). The historically documented poor outcomes of TVR are not the case when the indications are optimized. Surgery should be considered before the development of advanced heart failure or echocardiographic evidence of increased RV filling pressure.
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